1.S. Bastola, M. S. Pavlyukov, D. Yamashita, S. Ghosh, H. Cho, N. Kagaya,I. Nakano. Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy. Nat Commun. 2020; 11: 4660.
2.D. Hanahan, L. M. Coussens. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012; 21: 309-322.
3.C. Roma-Rodrigues, R. Mendes, P. V. Baptista, A. R. Fernandes. Targeting Tumor Microenvironment for Cancer Therapy. Int J Mol Sci. 2019; 20:
4.Ina Sevic, Fiorella Mercedes Spinelli, María José Cantero, Andrea Reszegi, Ilona Kovalszky, Mariana Gabriela García, Laura Alaniz. The Role of the Tumor Microenvironment in the Development and Progression of Hepatocellular Carcinoma. 2019; 29-45.
5.P. Heldin, K. Basu, B. Olofsson, H. Porsch, I. Kozlova, K. Kahata. Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer. J Biochem. 2013; 154: 395-408.
6.R. H. Tammi, A. Kultti, V. M. Kosma, R. Pirinen, P. Auvinen, M. I. Tammi. Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin Cancer Biol. 2008; 18: 288-295.
7.Marco P. Carvalho, Elisabete C. Costa, Sónia P. Miguel, Ilídio J. Correia. Tumor spheroid assembly on hyaluronic acid-based structures: A review. Carbohydrate Polymers. 2016; 150: 139-148.
8.N. Nagy, H. F. Kuipers, A. R. Frymoyer, H. D. Ishak, J. B. Bollyky, T. N. Wight, P. L. Bollyky. 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. Front Immunol. 2015; 6: 123.
9.Theerawut Chanmee, Pawared Ontong, Naoki Itano. Hyaluronan: A modulator of the tumor microenvironment. Cancer Letters. 2016; 375: 20-30.
10.Vinata B. Lokeshwar, Summan Mirza, Andre Jordan. Targeting Hyaluronic Acid Family for Cancer Chemoprevention and Therapy. 2014; 123: 35-65.
11.Davide Vigetti, Alberto Passi. Hyaluronan Synthases Posttranslational Regulation in Cancer. 2014; 123: 95-119.
12.F. M. Spinelli, D. L. Vitale, G. Demarchi, C. Cristina, L. Alaniz. The immunological effect of hyaluronan in tumor angiogenesis. Clin Transl Immunology. 2015; 4: e52.
13.T. J. Yates, L. E. Lopez, S. D. Lokeshwar, N. Ortiz, G. Kallifatidis, A. Jordan,V. B. Lokeshwar. Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer. J Natl Cancer Inst. 2015; 107:
14.A. M. Mueller, B. H. Yoon, S. A. Sadiq. Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS. J Biol Chem. 2014; 289: 22888-22899.
15.V. B. Lokeshwar, L. E. Lopez, D. Munoz, A. Chi, S. P. Shirodkar, S. D. Lokeshwar,N. Altman. Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells. Cancer Res. 2010; 70: 2613-2623.
16.H. Nagase, D. Kudo, A. Suto, E. Yoshida, S. Suto, M. Negishi,K. Hakamada. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells. Pancreas. 2017; 46: 190-197.
17.Hiroyuki Cho, Seiji Matsumoto, Yoshiko Fujita, Ayumi Kuroda, Toshi Menju, Makoto Sonobe,Seiki Hasegawa. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 2017; 12: 477-490.
18.Alec C. Kimmelman, Eileen White. Autophagy and Tumor Metabolism. Cell Metabolism. 2017; 25: 1037-1043.
19.D. Jiang, J. Liang, P. W. Noble. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011; 91: 221-264.
20.X. Zhang, L. Yu, H. Xu. Lysosome calcium in ROS regulation of autophagy. Autophagy. 2016; 12: 1954-1955.
21.Zoe Price, Noor Lokman, Carmela Ricciardelli. Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance. Cancers. 2018; 10: 482.
22.Ji-Feng Xu, Shui-Jun Zhang, Chen Zhao, Bin-Song Qiu, Hai-Feng Gu, Jian-Fei Hong,Ya-Ping Wang. Altered microRNA Expression Profile in Synovial Fluid from Patients with Knee Osteoarthritis with Treatment of Hyaluronic Acid. Molecular Diagnosis & Therapy. 2015; 19: 299-308.
23.W. Yue, A. Hamai, G. Tonelli, C. Bauvy, V. Nicolas, H. Tharinger,M. Mehrpour. Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance. Autophagy. 2013; 9: 714-729.
24.Q. T. Ostrom, H. Gittleman, J. Fulop, M. Liu, R. Blanda, C. Kromer,J. S. Barnholtz-Sloan. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. Neuro Oncol. 2015; 17 Suppl 4: iv1-iv62.
25.R. Stupp, W. P. Mason, M. J. van den Bent, M. Weller, B. Fisher, M. J. Taphoorn,Group National Cancer Institute of Canada Clinical Trials. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352: 987-996.
26.J. Bi, S. Chowdhry, S. Wu, W. Zhang, K. Masui, P. S. Mischel. Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets. Nat Rev Cancer. 2020; 20: 57-70.
27.H. H. Lin, Y. Chung, C. T. Cheng, C. Ouyang, Y. Fu, C. Y. Kuo,D. K. Ann. Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesis. Autophagy. 2018; 14: 1481-1498.
28.Jiurong Liang, Dianhua Jiang, Paul W. Noble. Hyaluronan as a therapeutic target in human diseases. Advanced Drug Delivery Reviews. 2016; 97: 186-203.
29.Véronique Orian-Rousseau, Jonathan Sleeman. CD44 is a Multidomain Signaling Platform that Integrates Extracellular Matrix Cues with Growth Factor and Cytokine Signals. 2014; 123: 231-254.
30.M. Long, T. G. McWilliams. Monitoring autophagy in cancer: From bench to bedside. Semin Cancer Biol. 2019;
31.S. Talukdar, A. K. Pradhan, P. Bhoopathi, X. N. Shen, L. A. August, J. J. Windle,P. B. Fisher. MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells. Proc Natl Acad Sci U S A. 2018; 115: 5768-5773.